Clinical Trials Directory

Trials / Sponsors / ADMA Biologics, Inc.

ADMA Biologics, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
UnknownAn Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in P
Primary Immune Deficiency
Phase 42022-09-01
CompletedStudy to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Humoral Immune Response
Phase 42016-12-29
UnknownA Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globuli
Primary Immune Deficiency Disorder
—2016-12-01
CompletedPharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseas
Primary Immune Deficiency Disorder
Phase 32014-02-01
CompletedRI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illn
Upper Respiratory Tract Infection, Lower Respiratory Tract Infection
Phase 22008-02-01
CompletedOpen Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primar
Primary Immune Deficiency Disorders (PIDD)
Phase 32007-09-01
TerminatedRandomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplant
Sequelae of Viral Hepatitis, Transplantation Infection, Evidence of Liver Transplantation
Phase 22007-05-01